2-237817038-A-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001080504.3(RBM44):āc.119A>Gā(p.Asn40Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000033 in 1,576,534 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001080504.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM44 | NM_001080504.3 | c.119A>G | p.Asn40Ser | missense_variant | 3/16 | ENST00000316997.9 | NP_001073973.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM44 | ENST00000316997.9 | c.119A>G | p.Asn40Ser | missense_variant | 3/16 | 5 | NM_001080504.3 | ENSP00000321179 | P1 | |
RBM44 | ENST00000409864.6 | c.119A>G | p.Asn40Ser | missense_variant | 3/15 | 5 | ENSP00000386727 | P1 | ||
RBM44 | ENST00000480583.5 | n.610A>G | non_coding_transcript_exon_variant | 3/15 | 2 | |||||
RBM44 | ENST00000444524.2 | n.202-3137A>G | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152086Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000501 AC: 11AN: 219584Hom.: 0 AF XY: 0.0000500 AC XY: 6AN XY: 120006
GnomAD4 exome AF: 0.0000323 AC: 46AN: 1424330Hom.: 0 Cov.: 29 AF XY: 0.0000310 AC XY: 22AN XY: 708666
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152204Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74432
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at